Summary of Study ST002284

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001464. The data can be accessed directly via it's Project DOI: 10.21228/M8GT5D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002284
Study TitleGenetically defined human GBM organoids reveal principles of GBM development and actionable targets
Study SummaryRecent advances in glioblastoma (GBM) studies provide a comprehensive catalog of its genetic aberrations and cellular heterogeneity. However, a solid understanding of genotype-based analysis of cancer pathway dependency and actionable target identification is required to transform GBM treatment into a personalized era. Here, we generated a spectrum of mutant iPSCs harboring frequent GBM mutations with CRISPR/Cas9 and profiled the organoids (LEGO: Laboratory Engineered Glioblastoma Organoid) derived from these iPSCs temporally on transcriptome, methylome, metabolome, lipidome, proteome, and phospho-proteome levels. We found that LEGOs form brain tumors in vivo and recapitulate critical features of human GBM. The multi-omics analysis discovered essential milestones driven by genetic heterogeneity during GBM progressions, such as lineage alteration, methylome rewriting, and metabolome/lipidome reprogramming, in concordance with altered pathway activity and drug response. This study provides a tool and research path to realizing genome-based personalized GBM therapy using novel advanced models.
Institute
DKFZ
DepartmentMolecular Neurogenetics
LaboratoryMolecular Neurogenetics
Last NameWang
First NameChangwen
AddressIm Neuenheimer Feld 581
Emailc.wang@dkfz-heidelberg.de
Phone+49 6221 42 3455
Submit Date2022-09-17
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2024-01-26
Release Version1
Changwen Wang Changwen Wang
https://dx.doi.org/10.21228/M8GT5D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001464
Project DOI:doi: 10.21228/M8GT5D
Project Title:Comparing water-soluble metabolites and lipid changes on human organoids and corresponding culture medium with different genotypes at different culturing stages
Project Summary:Quantitative metabolome and lipidome analysis of human brain organoids with different genetic mutations. Water-soluble metabolites were extracted from 1- and 4-month-old WT, PT, PTCC, and PTN organoids and their respective culture medium.
Institute:DKFZ
Department:Molecular Neurogenetics
Laboratory:Molecular Neurogenetics
Last Name:Wang
First Name:Changwen
Address:Im Neuenheimer Feld 581, Heidelberg, Baden-Wurttemberg, 69120, Germany
Email:c.wang@dkfz-heidelberg.de
Phone:+49 6221 42 3455
Publications:https://www.nature.com/articles/s41698-024-00500-5, https://pubmed.ncbi.nlm.nih.gov/38273014/
  logo